These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 231062)

  • 21. [Insulin assay in insulinoma].
    Zeng XJ
    Zhonghua Wai Ke Za Zhi; 1984 Jan; 22(1):13-8, 62. PubMed ID: 6097422
    [No Abstract]   [Full Text] [Related]  

  • 22. Editorial: Diagnosis of insulinoma.
    Lancet; 1974 Aug; 2(7877):385-6. PubMed ID: 4136659
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunoreactive insulin assay in insulinoma.
    Zeng XJ; Yao CZ; Zhong SX; Zhang JX; Zhu Y; Wu CY
    Chin Med J (Engl); 1983 Aug; 96(8):575-82. PubMed ID: 6315315
    [No Abstract]   [Full Text] [Related]  

  • 24. Stimulation of insulin release by glucose in a transplantable rat islet cell tumor.
    Masiello P; Wollheim CB; Janjic D; Gjinovci A; Blondel B; Praz GA; Renold AE
    Endocrinology; 1982 Dec; 111(6):2091-6. PubMed ID: 6183110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological modifications of insulin release in vitro from fuel-responsive transplantable insulinomas.
    Hoenig M; Ferguson DC; Matschinsky FM
    Endocrinology; 1984 Oct; 115(4):1496-9. PubMed ID: 6148233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of somatostatin to inhibit tolbutamide-induced insulin secretion in patients with insulinomas: a possible diagnostic tool.
    Lorenzi M; Gerich JE; Karam JH; Forsham PH
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1121-4. PubMed ID: 166088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biochemical diagnosis of insulinoma: correlations between blood glucose, blood insulin and the titer of plasma non-esterified fatty acids during fasting and during various diagnostic tests].
    Gorini M; Ghizzi A; Carlo Stella C; De Caro L
    Minerva Med; 1985 Sep; 76(37):1663-75. PubMed ID: 2995870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of diabetogenic action of calcitonin in subjects affected by insulinoma.
    Passariello N; Paolisso G; Iannuzzi F; Pizza G; Marrazzo G; Sgambato S; D'Onofrio F
    Diabete Metab; 1989; 15(2):88-92. PubMed ID: 2544469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood sugar, serum insulin and free fatty acid interrelationships during intravenous tolbutamide testing in normal young adults and in patients with insulinoma.
    Grunt JA; Pallotta JA; Soeldner JS
    Diabetes; 1970 Feb; 19(2):122-6. PubMed ID: 4313182
    [No Abstract]   [Full Text] [Related]  

  • 30. Somatostatin-tolbutamide test in hyperinsulinism due to beta-cell hyperplasia.
    Del Arbol JL; Jimenez Alonso J; Yañez AP
    Lancet; 1978 Feb; 1(8058):281-2. PubMed ID: 74709
    [No Abstract]   [Full Text] [Related]  

  • 31. Insulinoma: clinical manifestations, diagnosis and treatment. The significance of the prolonged fasting test and of the fasting blood glucose-insulin relationship.
    Johansen K
    J Endocrinol Invest; 1979; 2(3):285-90. PubMed ID: 231064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma.
    Thompson CS; O'Dorisio TM; Woltering EA
    Digestion; 1996; 57 Suppl 1():62-8. PubMed ID: 8813473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical diagnosis of insulinoma.
    Seyer-Hansen K; Lundbaek K
    Scand J Gastroenterol Suppl; 1979; 53():39-42. PubMed ID: 225785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition by somatostatin of tolbutamide-induced insulin secretion in a patient with an insulinoma.
    Van Kersen F
    Neth J Med; 1976; 19(1):5-7. PubMed ID: 175307
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin and glucose patterns in control subjects and in proved insulinoma.
    Khurana RC; Klayton R; Jung Y; Gonzalez AR; Dhawer VP; Corredor DG; Sieracki JC; Danowski TS
    Am J Med Sci; 1971 Aug; 262(2):115-28. PubMed ID: 4334960
    [No Abstract]   [Full Text] [Related]  

  • 36. Accurate localization of insulinoma using percutaneous transhepatic portal venous sampling--usefulness of simultaneous measurement of plasma insulin and glucagon levels.
    Kinoshita Y; Nonaka H; Suzuki S; Kondo T; Chihara K; Chiba T; Fujita T; Kotoura Y; Yamamura T
    Clin Endocrinol (Oxf); 1985 Nov; 23(5):587-93. PubMed ID: 3002671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A malignant insulinoma transformed into a glucagonoma syndrome.
    Ohneda A; Otsuki M; Fujiya H; Yaginuma N; Kokubo T; Ohtani H
    Diabetes; 1979 Nov; 28(11):962-9. PubMed ID: 226443
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients.
    Nauck M; Stöckmann F; Creutzfeldt W
    Eur J Clin Invest; 1990 Feb; 20(1):15-28. PubMed ID: 1969348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon test for insulinoma: a chemical study in 25 cases.
    Marks V; Samols E
    J Clin Pathol; 1968 May; 21(3):346-52. PubMed ID: 4301688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose intolerance in a patient with insulinoma. Report of a case.
    Christiansen J; Munkgaard S
    Acta Chir Scand; 1974; 140(7):578-80. PubMed ID: 4376322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.